North America In Vitro Diagnostics (IVD) Market 2021-2031 by Product (Instruments & Devices, Reagents & Kits, Software & Services), Technology (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics), Sample Type (Blood, Mucus, Urine), Application (Infectious Diseases, Diabetes, Cancer/Oncology), End User (Diagnostic Labs, Hospitals and Clinics, Homecare, POC), and Country: Trend Forecast and Growth Opportunity

August 2022 | 131 pages | ID: NC100DE33F4EEN
GMD Research

Abstracts

North America in vitro diagnostics (IVD) market is projected to grow by 5.6% annually in the forecast period and reach $ 54,000.3 million by 2031, driven by the increasing prevalence of chronic diseases along with the growing geriatric population, burgeoning demand for automation in diagnostics, the rising development of condition-specific treatment and booming awareness regarding personalized medicines, emergence of minimally invasive and non-invasive diagnostics tools & techniques, the rising healthcare expenditure, and rise in the demand for POC testing.

Highlighted with 25 tables and 60 figures, this 131-page report “North America In Vitro Diagnostics (IVD) Market 2021-2031 by Product (Instruments & Devices, Reagents & Kits, Software & Services), Technology (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics), Sample Type (Blood, Mucus, Urine), Application (Infectious Diseases, Diabetes, Cancer/Oncology), End User (Diagnostic Labs, Hospitals and Clinics, Homecare, POC), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America in vitro diagnostics (IVD) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America in vitro diagnostics (IVD) market in every aspect of the classification from perspectives of Product, Technology, Sample Type, Application, End User, and Country.

Based on Product, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Instruments & Devices
• Disposable IVD Devices
• Reusable IVD Devices
• Reagents & Kits
• Software & Services

Based on Technology, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Clinical Chemistry
• Molecular Diagnostics
• Immuno Diagnostics
• Hematology
• Tissue Diagnostics
• Microbiology
• Coagulation and Hemostasis
• Urinalysis
• Other Technologies

By Sample Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Blood
• Mucus
• Urine
• Other Sample Types

By Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Infectious Diseases
• Diabetes
• Cancer/Oncology
• Cardiology
• Autoimmune Disease
• Nephrology
• Drug Testing
• HIV/AIDS
• Other Applications

By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Diagnostic Laboratories
• Hospitals and Clinics
• Homecare Settings
• Point-of-Care (POC) Settings
• Other End Users

Geographically, the following national/local markets are fully investigated:

• U.S.
• Canada
• Mexico

For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product, Application and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

Abbott Laboratories, Inc.

Agilent Technologies, Inc.

Arkray Inc.

Becton, Dickinson and Company

Biomerieux SA

Bio-Rad Laboratories Inc.

Danaher Corporation

DiaSorin SpA (Luminex Corporation)

Epic Systems Corporation

F. Hoffmann-La Roche Ltd.

Genpact Limited

Grifols SA

IBM Corporation

Mckesson Corporation

Ortho Clinical Diagnostics Inc.

Qiagen NV

Quest Diagnostics Inc.

Quidel Corporation

Roche Diagnostics

Siemens Healthineers

Sysmex Corporation

Thermo Fisher Scientific Inc.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on World Economy
  2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF NORTH AMERICA MARKET BY PRODUCT

3.1 Market Overview by Product
3.2 Instruments & Devices
  3.2.1 Disposable IVD Devices
  3.2.2 Reusable IVD Devices
3.3 Reagents & Kits
3.4 Software & Services

4 SEGMENTATION OF NORTH AMERICA MARKET BY TECHNOLOGY

4.1 Market Overview by Technology
4.2 Clinical Chemistry
4.3 Molecular Diagnostics
4.4 Immuno Diagnostics
4.5 Hematology
4.6 Tissue Diagnostics
4.7 Microbiology
4.8 Coagulation and Hemostasis
4.9 Urinalysis
4.10 Other Technologies

5 SEGMENTATION OF NORTH AMERICA MARKET BY SAMPLE TYPE

5.1 Market Overview by Sample Type
5.2 Blood
5.3 Mucus
5.4 Urine
5.5 Other Sample Types

6 SEGMENTATION OF NORTH AMERICA MARKET BY APPLICATION

6.1 Market Overview by Application
6.2 Infectious Diseases
6.3 Diabetes
6.4 Cancer/Oncology
6.5 Cardiology
6.6 Autoimmune Disease
6.7 Nephrology
6.8 Drug Testing
6.9 HIV/AIDS
6.10 Other Applications

7 SEGMENTATION OF NORTH AMERICA MARKET BY END USER

7.1 Market Overview by End User
7.2 Diagnostic Laboratories
7.3 Hospitals and Clinics
7.4 Homecare Settings
7.5 Point-of-Care (POC) Settings
7.6 Other End Users

8 NORTH AMERICA MARKET 2021-2031 BY COUNTRY

8.1 Overview of North America Market
8.2 U.S.
8.3 Canada
8.4 Mexico

9 COMPETITIVE LANDSCAPE

9.1 Overview of Key Vendors
9.2 New Product Launch, Partnership, Investment, and M&A
9.3 Company Profiles
Abbott Laboratories, Inc.
Agilent Technologies, Inc.
Arkray Inc.
Becton, Dickinson and Company
Biomerieux SA
Bio-Rad Laboratories Inc.
Danaher Corporation
DiaSorin SpA (Luminex Corporation)
Epic Systems Corporation
F. Hoffmann-La Roche Ltd.
Genpact Limited
Grifols SA
IBM Corporation
Mckesson Corporation
Ortho Clinical Diagnostics Inc.
Qiagen NV
Quest Diagnostics Inc.
Quidel Corporation
Roche Diagnostics
Siemens Healthineers
Sysmex Corporation
Thermo Fisher Scientific Inc.
RELATED REPORTS

List Of Tables

LIST OF TABLES:

Table 1. Snapshot of North America In Vitro Diagnostics Market in Balanced Perspective, 2021-2031
Table 2. World Economic Outlook, 2021-2031
Table 3. World Economic Outlook, 2021-2023
Table 4. World Health Spending by Region, $ bn, 2013-2020
Table 5. Main Product Trends and Market Opportunities in North America In Vitro Diagnostics Market
Table 6. North America In Vitro Diagnostics Market by Product, 2021-2031, $ mn
Table 7. North America In Vitro Diagnostics Market: Instruments & Devices by Type, 2021-2031, $ mn
Table 8. North America In Vitro Diagnostics Market by Technology, 2021-2031, $ mn
Table 9. North America In Vitro Diagnostics Market by Sample Type, 2021-2031, $ mn
Table 10. North America In Vitro Diagnostics Market by Application, 2021-2031, $ mn
Table 11. Commercially Available COVID-19 Diagnostic Tests Approved in 2021-2022
Table 12. North America In Vitro Diagnostics Market by End User, 2021-2031, $ mn
Table 13. North America In Vitro Diagnostics Market by Country, 2021-2031, $ mn
Table 14. U.S. In Vitro Diagnostics Market by Product, 2021-2031, $ mn
Table 15. U.S. In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn
Table 16. U.S. In Vitro Diagnostics Market by End User, 2021-2031, $ mn
Table 17. Canada In Vitro Diagnostics Market by Product, 2021-2031, $ mn
Table 18. Canada In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn
Table 19. Canada In Vitro Diagnostics Market by End User, 2021-2031, $ mn
Table 20. Mexico In Vitro Diagnostics Market by Product, 2021-2031, $ mn
Table 21. Mexico In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn
Table 22. Mexico In Vitro Diagnostics Market by End User, 2021-2031, $ mn
Table 23. Abbott Laboratories, Inc.: Company Snapshot
Table 24. Abbott Laboratories, Inc.: Business Segmentation
Table 25. Abbott Laboratories, Inc.: Product Portfolio

List Of Figures

LIST OF FIGURES:

Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031
Figure 4. North America In Vitro Diagnostics Market, 2021-2031, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of North America In Vitro Diagnostics Market
Figure 7. Leading Causes of Death in the World, 2000 and 2019, million
Figure 8. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060
Figure 10. Primary Restraints and Impact Factors of North America In Vitro Diagnostics Market
Figure 11. Investment Opportunity Analysis
Figure 12. Porter’s Fiver Forces Analysis of North America In Vitro Diagnostics Market
Figure 13. Breakdown of North America In Vitro Diagnostics Market by Product, 2021-2031, % of Revenue
Figure 14. North America Addressable Market Cap in 2022-2031 by Product, Value ($ mn) and Share (%)
Figure 15. North America In Vitro Diagnostics Market by Product: Instruments & Devices, 2021-2031, $ mn
Figure 16. North America In Vitro Diagnostics Market by Instruments & Devices: Disposable IVD Devices, 2021-2031, $ mn
Figure 17. North America In Vitro Diagnostics Market by Instruments & Devices: Reusable IVD Devices, 2021-2031, $ mn
Figure 18. North America In Vitro Diagnostics Market by Product: Reagents & Kits, 2021-2031, $ mn
Figure 19. North America In Vitro Diagnostics Market by Product: Software & Services, 2021-2031, $ mn
Figure 20. Breakdown of North America In Vitro Diagnostics Market by Technology, 2021-2031, % of Sales Revenue
Figure 21. North America Addressable Market Cap in 2022-2031 by Technology, Value ($ mn) and Share (%)
Figure 22. North America In Vitro Diagnostics Market by Technology: Clinical Chemistry, 2021-2031, $ mn
Figure 23. North America In Vitro Diagnostics Market by Technology: Molecular Diagnostics, 2021-2031, $ mn
Figure 24. North America In Vitro Diagnostics Market by Technology: Immuno Diagnostics, 2021-2031, $ mn
Figure 25. North America In Vitro Diagnostics Market by Technology: Hematology, 2021-2031, $ mn
Figure 26. North America In Vitro Diagnostics Market by Technology: Tissue Diagnostics, 2021-2031, $ mn
Figure 27. North America In Vitro Diagnostics Market by Technology: Microbiology, 2021-2031, $ mn
Figure 28. North America In Vitro Diagnostics Market by Technology: Coagulation and Hemostasis, 2021-2031, $ mn
Figure 29. North America In Vitro Diagnostics Market by Technology: Urinalysis, 2021-2031, $ mn
Figure 30. North America In Vitro Diagnostics Market by Technology: Other Technologies, 2021-2031, $ mn
Figure 31. Breakdown of North America In Vitro Diagnostics Market by Sample Type, 2021-2031, % of Sales Revenue
Figure 32. North America Addressable Market Cap in 2022-2031 by Sample Type, Value ($ mn) and Share (%)
Figure 33. North America In Vitro Diagnostics Market by Sample Type: Blood, 2021-2031, $ mn
Figure 34. North America In Vitro Diagnostics Market by Sample Type: Mucus, 2021-2031, $ mn
Figure 35. North America In Vitro Diagnostics Market by Sample Type: Urine, 2021-2031, $ mn
Figure 36. North America In Vitro Diagnostics Market by Sample Type: Other Sample Types, 2021-2031, $ mn
Figure 37. Breakdown of North America In Vitro Diagnostics Market by Application, 2021-2031, % of Revenue
Figure 38. North America Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%)
Figure 39. North America In Vitro Diagnostics Market by Application: Infectious Diseases, 2021-2031, $ mn
Figure 40. North America In Vitro Diagnostics Market by Application: Diabetes, 2021-2031, $ mn
Figure 41. North America In Vitro Diagnostics Market by Application: Cancer/Oncology, 2021-2031, $ mn
Figure 42. North America In Vitro Diagnostics Market by Application: Cardiology, 2021-2031, $ mn
Figure 43. North America In Vitro Diagnostics Market by Application: Autoimmune Disease, 2021-2031, $ mn
Figure 44. North America In Vitro Diagnostics Market by Application: Nephrology, 2021-2031, $ mn
Figure 45. North America In Vitro Diagnostics Market by Application: Drug Testing, 2021-2031, $ mn
Figure 46. North America In Vitro Diagnostics Market by Application: HIV/AIDS, 2021-2031, $ mn
Figure 47. North America In Vitro Diagnostics Market by Application: Other Applications, 2021-2031, $ mn
Figure 48. Breakdown of North America In Vitro Diagnostics Market by End User, 2021-2031, % of Revenue
Figure 49. North America Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)
Figure 50. North America In Vitro Diagnostics Market by End User: Diagnostic Laboratories, 2021-2031, $ mn
Figure 51. North America In Vitro Diagnostics Market by End User: Hospitals and Clinics, 2021-2031, $ mn
Figure 52. North America In Vitro Diagnostics Market by End User: Homecare Settings, 2021-2031, $ mn
Figure 53. North America In Vitro Diagnostics Market by End User: Point-of-Care (POC) Settings, 2021-2031, $ mn
Figure 54. North America In Vitro Diagnostics Market by End User: Other End Users, 2021-2031, $ mn
Figure 55. Breakdown of North America In Vitro Diagnostics Market by Country, 2021 and 2031, % of Revenue
Figure 56. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 57. U.S. In Vitro Diagnostics Market, 2021-2031, $ mn
Figure 58. Canada In Vitro Diagnostics Market, 2021-2031, $ mn
Figure 59. In Vitro Diagnostics Market in Mexico, 2021-2031, $ mn
Figure 60. Growth Stage of North America In Vitro Diagnostics Industry over the Forecast Period